Select Publications

Conference Papers

Feng KY; Gogate J; Damaraju CV; Li J; Jardine MJ; Perkovic V; Blais JD; Pfeifer M; Neal B; Mahaffey KW, 2021, 'Canagliflozin Reduces All-cause Hospitalization in Patients with Type 2 Diabetes Mellitus', in METABOLISM-CLINICAL AND EXPERIMENTAL, W B SAUNDERS CO-ELSEVIER INC, pp. 17 - 18, http://dx.doi.org/10.1016/j.metabol.2020.154509

Tuttle KR; Brosius FC; Cavender MA; Fioretto P; Fowler KJ; Heerspink HJL; Manley T; McGuire DK; Molitch ME; Mottl AK; Perreault L; Rosas SE; Rossing P; Sola L; Vallon V; Wanner C; Perkovic V, 2021, 'Sglt2 inhibition for ckd and cardiovascular disease in type 2 diabetes: Report of a scientific workshop sponsored by the national kidney foundation', in Diabetes, pp. 1 - 16, http://dx.doi.org/10.2337/dbi20-0040

Mahaffey KW; Bakris G; Blais J; Cannon CP; Cherney D; Damaraju C; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Kosiborod M; Levin A; Lingvay I; Weir M; Perkovic V, 2020, 'Effects of canagliflozin on cardiovascular death and hospitalization for heart failure by baseline estimated glomerular filtration rate: integrated analyses from the CANVAS Program and CREDENCE', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 3316 - 3316, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000606106303323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mahaffey KW; Li J; Chang T; Sarraju A; Agarwal R; Charytan DM; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Yavin Y; Jardine M; Perkovic V; Cannon GP, 2020, 'Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 1175 - 1175, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000606106301178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 29 - 29, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 61, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jun M; Jardine M; Heerspink HL; Perkovic V; Badve S; Kotwal S; Gallagher M; Harris K; Chalmers J; Woodward M, 2020, 'VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE', in NEPHROLOGY, WILEY, pp. 22 - 22, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mahaffey KW; Bakris G; Blais J; Cannon C; Cherney D; Damaraju CV; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Kosiborod M; Levin A; Lingvay I; Weir M; Perkovic V, 2020, 'Effects of canagliflozin on cardiovascular death and hospitalisation for heart failure by eGFR: integrated analyses of the CANVAS Program and CREDENCE', in DIABETOLOGIA, SPRINGER, ELECTR NETWORK, pp. S267 - S268, presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWORK, 21 September 2020 - 25 September 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000565776600558&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mann JFE; Buse JB; Idorn T; Leiter LA; Pratley R; Rasmussen S; Vilsboll T; Wolthers B; Perkovic V, 2020, 'Renoprotection with semaglutide and liraglutide: Direct or indirect effects?', in DIABETOLOGIA, SPRINGER, ELECTR NETWORK, pp. S67 - S68, presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWORK, 21 September 2020 - 25 September 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000565776600135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

de Zeeuw D; Arnott C; Li J-W; Cannon CP; Neuen BL; Heerspink HJL; Neal B; Charytan DM; Bakris G; Chang T-H; Rosenthal N; Zinman B; Perkovic V; Jardine MJ; Mahaffey KW, 2020, 'The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial', in DIABETOLOGIA, SPRINGER, ELECTR NETWORK, pp. S61 - S62, presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWORK, 21 September 2020 - 25 September 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000565776600123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Lone E; Viecelli AK; Craig JC; Tong A; Sautenet B; Herrington WG; Herzog CA; Jafar TH; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AYM; Wanner C; Zannad F; Winkelmayer WC; Wheeler DC; Manns B; Pecoits-Filho R; Harris T; Winkelmayer W; Herzog CA; Kleinpeter M; Ju A; Cho Y; Gutman T; Bernier-Jean A; James L; Hamiwka L; Jardine A; Bello A; Stengel B; Schiller B; Johnson D; Bavlovlenkov E; Caskey F; Gillespie B; Block G; Phan HA; Heerspink HL; Madero M; Ruospo M; Unruh M; Laville M; Bansal N; Mark P; Blankestijn PJ; Roy-Chaudhury P; Perlman R; Agarwal R; Mehrotra R; Seliger S; Shafi T; Hiemstra T; Jassal V; Perkovic V; Simplice A; White D; Eilers D; Alexander H; Landry Y; Landry G; Wilkie C, 2020, 'Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop', in American Journal of Kidney Diseases, pp. 109 - 120, http://dx.doi.org/10.1053/j.ajkd.2020.01.022

Li J; Neal B; Heerspink HL; Arnott C; Cannon C; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Greene T; Levin A; Oh R; Pollock CA; Wheeler DC; Yavin Y; Zhang H; Zinman B; Di Tanna GL; Perkovic V; Mahaffey KW; Jardine M, 2020, 'Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)', in DIABETES, AMER DIABETES ASSOC, ELECTR NETWORK, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-1130-P

Levey AS; Gansevoort RT; Coresh J; Inker LA; Heerspink HL; Grams ME; Greene T; Tighiouart H; Matsushita K; Ballew SH; Sang Y; Vonesh E; Ying J; Manley T; de Zeeuw D; Eckardt KU; Levin A; Perkovic V; Zhang L; Willis K, 2020, 'Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency', in American Journal of Kidney Diseases, pp. 84 - 104, http://dx.doi.org/10.1053/j.ajkd.2019.06.009

Cannon CP; Perkovic V; Agarwal R; Baldassarre J; Bakris GL; Brenner BM; Charytan D; de Zeeuw D; Edwards R; Greene T; Heerspink HJL; Jardine M; Levin A; Li J-W; Neal B; Pollock C; Wheeler D; Zhang H; Zinman B; Mahaffey KW, 2019, 'Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c < 7%: Results From the CREDENCE Trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Philadelphia, PA, presented at Scientific Sessions of the American-Heart-Association, Philadelphia, PA, 16 November 2019 - 18 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000529998005266&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Baigent C; Herrington WG; Coresh J; Landray MJ; Levin A; Perkovic V; Pfeffer MA; Rossing P; Walsh M; Wanner C; Wheeler DC; Winkelmayer WC; McMurray JJV; Abu-Alfa A; Archdeacon P; Block GA; Caskey FJ; Cheung AK; Cooper B; Craig JC; Dember LM; Eknoyan G; Gansevoort RT; Gill JS; Gillespie B; Greene T; Harris DC; Haynes R; Hemmelgarn BR; Herzog CA; Hiemstra TF; Inker LA; Jardine MJ; Jha V; Jiang L; Johansen KL; Kewalramani R; Lambers Heerspink HJ; Lefkowitz M; Lok CE; Loud F; Mačiulaitis R; Maddux DW; Maddux FW; Madero M; Mariz S; Mauer M; Nally JV; Nangaku M; Okpechi IG; Parfrey PS; Pecoits-Filho R; Pereira BJG; Rocco MV; Rossignol P; Schaefer F; Tentori F; Thompson A; Tonelli M; Tong A; Toto RD; Tuttle KR; Vetter T; Moon Wang AY; Zannad F, 2016, 'Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference', in Kidney International, Paris, France, pp. 297 - 305, presented at KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology, Paris, France, 08 September 2016 - 11 September 2016, http://dx.doi.org/10.1016/j.kint.2017.04.019

Heerspink HJL; Desai M; Jardine M; Meininger G; Perkovic V, 2016, 'Canagliflozin (CANA) Slows Progression of Renal Function Decline Independent of Glycemic Effects', in DIABETES, AMER DIABETES ASSOC, New Orleans, LA, pp. A18 - A18, presented at 76th Scientific Sessions of the American-Diabetes-Association, New Orleans, LA, 10 June 2016 - 14 June 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398372800070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gallagher M; Jardine M; Cass A; McDonald S; Perkovic V; Petrie J; Eris J, 2007, '20 year outcomes of the Australian multicentre randomised trial of cyclosporine withdrawal in renal transplantation.', in AMERICAN JOURNAL OF TRANSPLANTATION, BLACKWELL PUBLISHING, San Francisco, CA, pp. 206 - 207, presented at Annual American Transplant Congress, San Francisco, CA, 05 May 2007 - 09 May 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246370200232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kerr P; Perkovic V; Petrie J; Agar J; Disney A, 2005, 'Dialysis adequacy (HD) guidelines: Dose of haemodialysis', in Nephrology, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_1.x

Masterson R; Leikis M; Perkovic V; Nicholls K; Walker R, 2003, 'Sirolimus: A single center experience in combination with calcineurin inhibitors', in Transplantation Proceedings, pp. S99 - S104, http://dx.doi.org/10.1016/S0041-1345(03)00219-7


Back to profile page